No Data
On December 31, A-share investment warning: Zhejiang Wecome Pharmaceutical and its actual controller Liu Zhongliang are being investigated by the China Securities Regulatory Commission for suspected violations of information disclosure laws.
Guo Yongfang, a shareholder of China Investment Technology, plans to reduce his shareholding by no more than 1%; Xiao Jinming, a shareholder of YingTong Telecommunication, intends to decrease his shareholding by no more than 2.47%; Mingchun Technology, a shareholder of Jingsheng Co., plans to reduce its stake by no more than 2%; Anyuan Coal Industry Group has not yet obtained the "Free Transfer Agreement" signed with Jiangneng Group and Jiangte Holdings; Zhongbai Holdings Group has not yet received the specific implementation plan from Wuhan Business Alliance; Zhejiang Wecome Pharmaceutical and its actual controller Liu Zhongliang are under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure regulations.
Gelonghui Announcement Highlights | Xinyangfeng Agricultural Technology: Plans to invest approximately 9.6 billion yuan to build a phosphate-based New Materials Circular Economy industrial park project; Zhejiang Sanhua Intelligent Controls: Plans to spend
【Hotspot Tracking】Zhongbai Holdings Group (000759.SZ): No specific implementation plan from Wuhan Merchants Union received yet. ST Zhiyun (300097.SZ): The Chairman and General Manager received the "Decision on Lifting the Release from Bail". Anyuan Coal Industry Group (600397.SH): Has not yet obtained the "Agreement on Free Transfer" signed between Jiangneng Group and Jiangte Holdings. 【Project Investment】Xinyangfeng Agricultural Technology (000902.SZ): Plans to invest about 9.6 billion yuan to build a phosphate-based New Materials Circular Economy Industrial Park project. Sichuan Guangan AAA Public (600979.SH): The subsidiary plans to provide 10KV distribution engineering installation services for the construction project of Aizhong.
Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) Insiders, Who Hold 70% of the Firm Would Be Disappointed by the Recent Pullback
Zhejiang Wecome Pharmaceutical (300878.SZ): Change of pharmaceutical production license.
November 13, GeLongHui丨Zhejiang Wecome Pharmaceutical (300878.SZ) announced that the company recently obtained the "pharmaceutical production license" issued by the Zhejiang Provincial Food and Drug Administration, agreeing to the application for change of the "pharmaceutical production license". This change mainly involves the change of the company's legal representative.
Weikang Pharmaceutical: Report for the third quarter of 2024
Zhejiang Wecome Pharmaceutical (300878.SZ) released its performance for the first three quarters, with a net income of 44.1 million yuan, a year-on-year decrease of 36.41%.
zhejiang wecome pharmaceutical (300878.SZ) disclosed its third quarter report for 2024, achieving revenue of 3....
Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected
No Data
